Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct
Sheela Rao, Francesco Sclafani, Cathy Eng, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 22, pp. 2510-2518
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Sheela Rao, Marianne G. Guren, Khurum Khan, et al.
Annals of Oncology (2021) Vol. 32, Iss. 9, pp. 1087-1100
Open Access | Times Cited: 172
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 22
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 5, pp. 446-454
Open Access | Times Cited: 58
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
Sheela Rao, Gayathri Anandappa, Jaume Capdevila, et al.
ESMO Open (2022) Vol. 7, Iss. 4, pp. 100529-100529
Open Access | Times Cited: 53
Anal Cancer: Emerging Standards in a Rare Disease
Cathy Eng, Kristen K. Ciombor, May Cho, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2774-2788
Closed Access | Times Cited: 43
Anal Cancer: The Past, Present and Future
Talha Ashraf Gondal, Noman Chaudhary, Husnaat Bajwa, et al.
Current Oncology (2023) Vol. 30, Iss. 3, pp. 3232-3250
Open Access | Times Cited: 41
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Stéfano Kim, François Ghiringhelli, Christelle de la Fouchardière, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 4, pp. 518-528
Open Access | Times Cited: 10
Programmed cell death, redox imbalance, and cancer therapeutics
Xiaofeng Dai, Danjun Wang, Jianying Zhang
APOPTOSIS (2021) Vol. 26, Iss. 7-8, pp. 385-414
Closed Access | Times Cited: 50
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
Ronan J. Kelly, Katherine M. Bever, Joseph Chao, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006658-e006658
Open Access | Times Cited: 17
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
Sara Lonardi, Alessandra Anna Prete, Federica Morano, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e002996-e002996
Open Access | Times Cited: 36
Immunotherapy in Anal Cancer
Natasha Dhawan, Muhammad Zubair Afzal, Manik Amin
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4538-4550
Open Access | Times Cited: 16
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Linheng Li, Roy A. Jensen
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2096-2104
Open Access | Times Cited: 14
What does person‐centred care mean, if you weren't considered a person anyway: An engagement with person‐centred care and Black, queer, feminist, and posthuman approaches
Jamie Smith, Eva Willis, Jane Hopkins‐Walsh
Nursing Philosophy (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 22
Immunotherapy in advanced anal cancer: Is the beginning of a new era?
Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, et al.
Cancer Treatment Reviews (2022) Vol. 105, pp. 102373-102373
Closed Access | Times Cited: 20
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
V. Vendrely, C. Lemanski, P. Pommier, et al.
Radiotherapy and Oncology (2023) Vol. 183, pp. 109542-109542
Open Access | Times Cited: 12
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M. Huffman, Harshabad Singh, Lestat R. Ali, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008436-e008436
Open Access | Times Cited: 4
Cancer anal : traitements
C. Naessens, N. Giraud, Anne Rullier, et al.
EMC - Gastro-entérologie (2025) Vol. 42, Iss. 1, pp. 1-7
Closed Access
An overview of clinical trials in anal cancer 1999-2024
D. Verschoor, E.S.L. Pedersen, A. Tardit, et al.
ESMO Gastrointestinal Oncology (2025), pp. 100145-100145
Open Access
[18F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry
Ur Metser, Jelena Luković, Aruz Mesci, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.269289-jnumed.124.269289
Closed Access
Clinicopathologic Features Associated with Survival for Immune Checkpoint Blockade in Patients with Metastatic Anal Cancer
Arjun Peddireddy, Ryan Huey, Robert A. Wolff, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 937-937
Open Access
Therapy for squamous-cell carcinoma of the anus in HIV-positive patients
C. Evin, Marcos Pedro Guedes Camandaroba, Rachel P. Riechelmann, et al.
ESMO Gastrointestinal Oncology (2025), pp. 100156-100156
Open Access
Advances in the Management, Treatment, and Surveillance of Anal Squamous Cell Cancer
Cynthia Araradian, Maura Walsh, Hayley Standage, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1289-1289
Open Access
Management of Squamous Cell Carcinomas of the Anal Canal and Anal Margin After Failure of Chemoradiotherapy Treatment: A Narrative Review
Michaël Racine, G. Meurette, Frédéric Ris, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1511-1511
Open Access
Anal canal cancer
Carlos Frederico Lopes Benevides, Isabela Dias Marques da Cruz, Fernando Nunes Galvão de Oliveira
Elsevier eBooks (2025), pp. 299-310
Closed Access
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma
Stéfano Kim, Aurélia Meurisse, Laurie Spehner, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top